Ever-Glory Biotech held its annual general meeting on May 22, 2026. Key resolutions included the approval of the 2025 profit distribution plan, as well as the business report and financial statements for the same year. The meeting also approved amendments to the articles of incorporation and the procedures for lending funds to others, along with the full re-election of the board of directors (including independent directors). Additionally, the release of non-compete restrictions for new directors was approved.

FACT BOX

  • Source: PR Times
  • Category: Shareholder Meeting Resolution